It is interesting to note that they are subjecting the controls to a treatment that is guaranteed to be useless but that is the nature of trials (not a criticism) and this trial is much better in design than the Celgro trial (which admittedly is hard to do any other way). This is a proper randomised controlled trial but there will be no potential upside for the controls.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004016/epdf/full
The primary outcome is tendon regeneration assessed by MRI.This will show whether the tendon has repaired itself, tendons don't repair themselves generally. The secondary outcomes are also important as a degree of tendon repair without much improvement in pain/function is of little value
As someone who has one of these injuries I will be watching closely though I have to admit the results will have to be pretty good before I let someone biopsy my patella tendon to fix something I have lived with for years, no doubt at large expense.
The alternative treatments for partial tears is physio and live with them with a variable amount of disability or have surgery. Based on the study protocol, the post injection restrictions are vastly preferable to surgery, so if this study is a success this stuff will be a winner.
It should be noted that they are only looking at 1 particular tendon which admittedly is the tendon most commonly torn and they are excluding the elderly who represent a large cohort of tears.
- Forums
- ASX - By Stock
- OCC
- Ann: Orthocells Ortho-ATI shows 82% success rate
Ann: Orthocells Ortho-ATI shows 82% success rate, page-6
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $82.68M |
Open | High | Low | Value | Volume |
40.0¢ | 40.0¢ | 39.0¢ | $65.71K | 166.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1052 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 354895 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1052 | 0.395 |
4 | 130389 | 0.390 |
2 | 7500 | 0.385 |
3 | 56825 | 0.380 |
3 | 25500 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 354895 | 8 |
0.405 | 11143 | 1 |
0.410 | 119177 | 7 |
0.415 | 3200 | 1 |
0.420 | 19017 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |